Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
A) Disease-free survival, (B) progression-free survival and (C)... | Download Scientific Diagram
Kaplan-Meier Estimates of Disease-free Survival and Overall Survival in... | Download Scientific Diagram
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram
Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials - European Journal of Cancer
Disease Free Survival - an overview | ScienceDirect Topics
Kaplan-Meier survival curves for disease-free survival and overall... | Download Scientific Diagram
The Essentials of GI Malignancies: Maximizing the Therapeutic Potential
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
VisualAbstract: Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer | 2 Minute Medicine
Disease Free Survival - an overview | ScienceDirect Topics
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
The value of progression-free survival to patients with advanced-stage cancer | Semantic Scholar
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
Overall survival (a) and disease-free survival (b) among the entire... | Download Scientific Diagram
PLOS ONE: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma
View Image
Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? - NCBI Bookshelf
